Clinical Trials Directory

Trials / Unknown

UnknownNCT02255669

Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction

Comparison Between Fully Covered and Partially Covered Self-expandable Metal Stents With Anti-migration System for Malignant Distal Biliary Obstruction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
106 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the duration of stent patency between partially covered and fully covered SEMS for palliation of malignant distal bile duct obstruction.

Detailed description

Endoscopic stent placement has been used as a principle palliative method in patients with unresectable distal malignancy biliary obstruction. It has been pivotal in providing relief from obstructive jaundice, improving the quality of life, and allowing the maintenance of chemotherapy. Although SEMSs have been reported to be superior to plastic stents in terms of stent patency, they still have some debatable issues ; in uncovered SEMS, stent occlusion due to epithelial hyperplasia and tumor ingrowth through the metal mesh is a frequent problem, whereas covered SEMSs are prone to migration. The aim of the current study is to compare the duration of stent patency between partially covered and fully covered SEMS as a primary objective, and investigate overall patient survival, stent occlusion rate, and incidence of adverse events including stent dysfunction as secondary objectives.

Conditions

Interventions

TypeNameDescription
DEVICEpartially covered SEMSUsed for palliation of inoperable malignant distal bile duct obstruction.
DEVICEfully covered SEMSUsed for palliation of inoperable malignant distal bile duct obstruction.

Timeline

Start date
2014-10-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2014-10-02
Last updated
2015-02-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02255669. Inclusion in this directory is not an endorsement.